- ISIN
- US45783Q1004
- CUSIP
- 45783Q100
- Delisting Date
- Jun 11, 2026
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Nov 25, 1997
Highlights
- Market Cap
- $502.47K
- Enterprise Value
- $818.80M
- EPS (TTM)
- -$2.56
- Total Revenue (TTM)
- $507.36M
- Gross Profit (TTM)
- $64.03M
- EBITDA (TTM)
- $27.31M
- Year Range
- $0.01 - $2.44
- Target Price
- $3.00
- ROA (TTM)
- -12.56%
- ROE (TTM)
- -114.46%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NOTV Performance Chart
Loading charts...
Returns By Period
Inotiv, Inc. (NOTV) has returned -97.42% so far this year and -99.28% over the past 12 months. Over the last ten years, NOTV has returned -34.58% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.
Inotiv, Inc.
- 1D
- -16.91%
- 1M
- -94.63%
- YTD
- -97.42%
- 6M
- -97.76%
- 1Y
- -99.28%
- 3Y*
- -86.01%
- 5Y*
- -78.09%
- 10Y*
- -34.58%
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
NOTV Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.99% | -45.89% | 0.66% | 6.46% | -1.41% | -94.93% | -97.42% | ||||||
| 2025 | 3.38% | -28.04% | -28.25% | -10.86% | 31.98% | -30.00% | 10.44% | -15.92% | -14.20% | -8.28% | -30.41% | -39.27% | -86.42% |
| 2024 | -9.81% | 125.08% | 46.85% | -64.90% | -51.30% | -11.23% | 15.66% | -21.87% | 13.33% | 4.12% | 106.78% | 13.11% | 12.81% |
| 2023 | 46.76% | 3.45% | -42.27% | 27.94% | 9.75% | -21.55% | 52.62% | -48.63% | -17.65% | -37.99% | 29.32% | 48.58% | -25.71% |
| 2022 | -23.96% | -17.38% | -0.95% | -45.57% | 7.37% | -37.25% | 94.58% | 4.76% | -13.90% | 23.32% | -70.93% | -18.21% | -88.26% |
| 2021 | -6.10% | 47.53% | 17.37% | 18.10% | 5.33% | 7.23% | -2.10% | -0.34% | 12.33% | 65.49% | 7.46% | -19.10% | 242.03% |
Benchmark Metrics
Inotiv, Inc. has an annualized alpha of 20.50%, beta of 0.45, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since November 25, 1997.
- This stock participated in 195.78% of S&P 500 Index downside but only 107.90% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.45 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 20.50%
- Beta
- 0.45
- R²
- 0.01
- Upside Capture
- 107.90%
- Downside Capture
- 195.78%
Return for Risk
Risk / Return Rank
NOTV ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Inotiv, Inc. (NOTV) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOTV | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.33 | ||
| Sortino ratioReturn per unit of downside risk | -5.09 | ||
| Omega ratioGain probability vs. loss probability | 0.66 | 1.32 | -0.67 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 2.46 | -3.46 |
| Martin ratioReturn relative to average drawdown | -1.49 | 10.92 | -12.41 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Inotiv, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Inotiv, Inc. was 99.97%, occurring on Jun 18, 2026. The portfolio has not yet recovered.
The current Inotiv, Inc. drawdown is 99.97%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.97%Jun 2026 | 4y 6mo | — | 4y 7moNov 2021 - now |
Financial crisis2007–2009 | -95.68%Jul 2009 | 8y 6d | 11y 5mo | 19y 5moJul 2001 - Jan 2021 |
Dot-com crash2000–2002 | -79.20%Dec 2000 | 2y 9mo | 6mo 9d | 3y 3moMar 1998 - Jul 2001 |
2021 bear market2021 | -42.68%Sep 2021 | 7d | 1mo 3d | 1mo 10dSep 2021 - Nov 2021 |
2021 bear market2021 | -30.84%Mar 2021 | 12d | 16d | 28dMar 2021 - Apr 2021 |
Drawdown Indicators
| NOTV | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -56.78% | -43.19% |
Max Drawdown (1Y)Largest decline over 1 year | -99.39% | -9.10% | -90.29% |
Max Drawdown (3Y)Largest decline over 3 years | -99.87% | -18.90% | -80.97% |
Max Drawdown (5Y)Largest decline over 5 years | -99.97% | -25.43% | -74.54% |
Max Drawdown (10Y)Largest decline over 10 years | -99.97% | -33.92% | -66.05% |
Current DrawdownCurrent decline from peak | -99.97% | -3.21% | -96.76% |
Average DrawdownAverage peak-to-trough decline | -73.01% | -10.71% | -62.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 66.62% | 2.04% | +64.58% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Inotiv, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Inotiv, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NOTV relative to other companies in the Diagnostics & Research industry. Currently, NOTV has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NOTV in comparison with other companies in the Diagnostics & Research industry. Currently, NOTV has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NOTV
Add Inotiv, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NOTV